Plain-English translation of NCT06989957 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
This research study is testing whether and , given together in a single session, can help treat post-traumatic stress disorder (PTSD) in military veterans. The study will compare two different dosing approaches to see which works better. You would receive the medication in a carefully supervised research setting with trained clinicians present.
Standard treatments for PTSD don't work well for everyone, and many veterans continue to struggle with symptoms despite available therapies. Researchers believe this medication combination might help unlock new healing pathways when used alongside professional support.
You likely qualify if…
You likely don't qualify if…
You would attend two medication sessions roughly six weeks apart. During each session, you would take the medication under close medical supervision at the research facility, with a clinician present throughout. You would need to arrange for a trusted friend or family member to pick you up afterward and stay with you. The study also requires you to follow specific rules about what other medications and substances you can take in the days before each session, and to maintain stable therapy if you are already in counseling.
AI-generated summary from trial data · Sep 15, 2026 · Not medical advice
United States